Success Metrics

Active Trials
1(100%)

Phase Distribution

Ph phase_1
1
100%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

active_not_recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
active_not_recruitingphase_1

Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine

NCT03854110

Clinical Trials (1)

Showing 1 of 1 trials
NCT03854110Phase 1

Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine

Active Not Recruiting

All 1 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
1